Companies / Roivant Sciences Ltd.
Roivant Sciences Ltd.
Nasdaq: ROIVCIK 1635088LONDON
Financials · FY2025
Ownership
722.3M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 6.92% | 50,014,504 |
| 10%+ / strategic | 9.11% | 65,779,464 |
| Institutions | 63.45% | 458,323,126 |
| Public float | 20.52% | 148,205,921 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 12
View all →| Insider | % of shares | Shares |
|---|---|---|
Sukhatme MayukhPresident & CIO · Director | 2.61% | 18,836,547 |
Manchester Keith SDirector | 2.14% | 15,437,569 |
Gold Daniel AllenFormerDirector | 2.09% | 15,127,329 |
Torti FrankPresident and Vant Chair | 1.90% | 13,736,547 |
| 1.90% | 13,689,166 | |
Venker EricCEOPresident & Immunovant CEO | 0.23% | 1,647,546 |
| 0.03% | 236,867 | |
Oren IlanDirector | 0.02% | 119,428 |
Momtazee James CFormerDirector | 0.02% | 109,405 |
Humes JenniferFormerChief Accounting Officer | 0.01% | 97,729 |
Institutional holders 415
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.71B | 6.68% | |
| $1.43B | 9.11% | |
| $1.27B | 8.08% | |
| $912.68M | 5.82% | |
| $696.97M | 3.48% | |
| $629.80M | 2.46% | |
| $399.08M | 2.55% | |
| $356.18M | 2.27% | |
| $354.40M | 1.77% | |
| $282.11M | 1.41% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Torti Frank Executive | Sell | Common Shares | $38.39M | -1.4M -9.25% | 13,736,547 1.90% of shares | high |
| Feb 20, 2026 | Torti Frank Executive | Sell | Common Shares | $27.49M | -1.0M -6.87% | 13,736,547 1.90% of shares | high |
| Jun 29, 2026 | QVT Financial LP | Sell | Common Shares | $20.75M | -600K -4.20% | 13,701,546 1.90% of shares | high |
| Jun 29, 2026 | Manchester Keith S Director | Sell | Common Shares | $20.75M | -600K -4.20% | 13,701,546 1.90% of shares | high |
| Feb 23, 2026 | Torti Frank Executive | Sell | Common Shares | $16.16M | -587K -4.10% | 13,736,547 1.90% of shares | high |
| Feb 11, 2026 | Gold Daniel Allen Director | Sell | Common Shares | $11.33M | -425K -2.60% | 15,928,113 2.21% of shares | high |
| Feb 11, 2026 | Manchester Keith S Director | Sell | Common Shares | $11.33M | -425K -2.60% | 15,928,113 2.21% of shares | high |
| Feb 11, 2026 | QVT Financial LP | Sell | Common Shares | $11.33M | -425K -2.60% | 15,928,113 2.21% of shares | high |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Ramaswamy Vivek | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
| Morgan Stanley | Passive13G/A | — |
| Sb Investment Advisers (Uk) Ltd | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ROIV | — | G76279101 |